Latest Institutional Placement News

Syntara Limited offers existing shareholders a discounted share purchase plan to raise about $2 million, following a recent $8 million institutional placement to fund clinical trials and licensing.

Pacific Edge launches a NZ$6 million retail share offer at NZ$0.17 per share following a NZ$25.4 million institutional placement, aiming to strengthen its balance sheet and support Medicare reimbursement efforts for its bladder cancer diagnostics.

Elevra Lithium has raised A$275 million through a fully underwritten institutional placement to fund its North American Lithium expansion and Moblan project development, supported by strong institutional demand.

Dateline Resources has delivered a comprehensive Bankable Feasibility Study for its Colosseum Gold Project in California, outlining a technically straightforward restart with strong financial metrics and a 10.4-year mine life producing 573,000 ounces of gold.

Cash Converters reports solid 1H26 results driven by a growing loan book, expanding luxury retail footprint, and increased corporate store ownership across 15 countries.

Asara Resources has raised $60 million through a strongly supported institutional placement to fast-track drilling and development at its flagship Kada Gold Project in Guinea.

Waratah Minerals has secured a A$48 million institutional placement to fund an accelerated drilling campaign at its Spur Gold Project, aiming for a maiden resource estimate in early 2027.

Lindian Resources reports steady progress at its Kangankunde Rare Earths Project in Malawi, maintaining schedule for first production in late 2026 with key infrastructure and regulatory milestones achieved.

Finder Energy has launched a $3 million Share Purchase Plan offering eligible shareholders in Australia and New Zealand the chance to buy shares at $0.50 each, a 15% discount to recent prices. The funds will accelerate engineering and procurement for the KTJ oil project.

ImpediMed has secured A$15.2 million through a two-tranche placement and share purchase plan, alongside A$5 million in cost reductions, aiming for operating cashflow breakeven by H2 FY28.

American West Metals (ASX: AW1) has raised A$10 million through an oversubscribed institutional placement to fast-track exploration at its West Desert and Storm Copper projects, focusing on high-demand critical metals.

Cynata Therapeutics has secured A$1.5 million through an institutional placement priced at a 22.5% discount, aiming to extend its cash runway ahead of pivotal Phase 3 and Phase 2 trial results expected in May and June 2026.